SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-20-000119
Filing Date
2020-12-14
Accepted
2020-12-14 16:41:10
Documents
5
Period of Report
2020-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bardaopiant8-krevision.htm 8-K 24912
2 EX-10.1 barda_modification.htm EX-10.1 1995
3 GRAPHIC barda_modification001.jpg GRAPHIC 131697
4 GRAPHIC barda_modification002.jpg GRAPHIC 109199
5 EX-99.1 opiantpressreleasebard.htm EX-99.1 9462
  Complete submission text file 0001385508-20-000119.txt   369692
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 201386654
SIC: 2834 Pharmaceutical Preparations